Regulation of pentraxin-3 by antioxidants

British Journal of Anaesthesia

Volumn 103, Issue 6, 2009, Pages 833-839

  Hill, A L ^a   Lowes, D A ^a   Webster, N R ^a   Sheth, C C ^b   Gow, N A R ^b   Galley, H F ^a  

^a School of Medicine and Dentistry   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Immune response; Infection, bacterial; Infection, fungal; Metabolism, protein, acute phase

Indexed keywords

ACETYLCYSTEINE; IDEBENONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPID HYDROPEROXIDE; LIPOPOLYSACCHARIDE; PENTRAXIN 3; PEPTIDOGLYCAN; TROLOX C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SEX DIFFERENCE;

EID: 71749103249     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep298     Document Type: Article

References (40)

1. Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008; 28: 1-13
2. Bottazzi B, Bastone A, Doni A, et al. The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility. J Leukoc Biol 2006; 79: 909-12
3. Breviario F, d'Aniello EM, Golay J, et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component. J Biol Chem 1992; 267: 22190-7
4. Lee GW, Lee TH, Vilcek J. TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentraxin family of acute phase proteins. J Immunol 1993; 150: 1804-12
5. Vidal Alles V, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 1994; 84: 3483-93
6. Pfaller M, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 31: 327-32 (Pubitemid 28212061)
7. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 1988; 148: 2642-5
8. Basile A, Sica A, D'Aniello E, et al. Characterization of the promoter for the human long pentraxin PTX3. J Biol Chem 1997; 272: 8172-8
9. Altmeyer A, Klampfer L, Goodman AR, Vilcek J. Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor interleukin-1-inducible pentraxin protein. J Biol Chem 1995; 270: 25584-90
10. Goode HF, Cowley HC, Walker BE, Webster NR. Decreased antioxidant status and increased lipid peroxidation in patients with sepsis and secondary organ dysfunction. Crit Care Med 1995; 23: 646-51
11. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: A comparison of survivors and non-survivors. Crit Care Med 1996; 24: 1179-83
12. Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Rad Biol Med 1997; 23: 768-74
13. Berger MM, Chioléro RL. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007; 35: S584-90
14. Andresen M, Regueira T, Bruhn A, et al. Lipoperoxidation and protein oxidative damage exhibit different kinetics during septic shock. Mediators Inflamm 2008, doi:10.1155/2008/168652 (Pubitemid 352000401)
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74
16. Lowes DA, Thottakam BMVJ, Webster NR, Murphy MP, Galley HF. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Rad Biol Med 2008; 45: 1559-65
17. Walker LA, MacCallum DM, Bertram G, Gow NA, Odds FC, Brown AJ. Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. Fungal Gen Biol 2009; 46: 210-9
18. Goode HF, Richardson N, Myers DS, Walker BE, Howdle PD, Webster NR. The effect of anticoagulant choice on apparent total antioxidant capacity using three different methods. Ann Clin Biochem 1995; 32: 413-6
19. Polentarutti N, Bottazzi B, Di Santo E, et al. Inducible expression of the long pentraxin PTX3 in the central nervous system. J Neuroimmunol 2000; 106: 87-94
20. Filler SG, Pfunder AS, Spellberg BJ, Spellberg JP, Edwards JE Jr. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect Immun 1996; 64: 2609-17
21. Filler SG, Swerdloff JN, Hobbs C, Luckett PM. Penetration and damage of endothelial cells by Candida albicans. Infect Immun 1995; 63: 976-83
22. Phan QT, Filler SG. Endothelial cell stimulation by Candida albicans. Methods Mol Biol 2009; 470: 313-6
23. Orozco AS, Zhou X, Filler SG. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect Immun 2000; 68: 1134-41
24. Rapponi G, Ghezzi MC, Mancini C, Filadoro F. Culture filtrates and whole heat-killed Candida albicans stimulate human monocytes to release interleukin-6. Microbiologica 1993; 16: 267-74
25. Muller B, Peri G, Doni A, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001; 29: 1404-7
26. Mauri T, Coppadoro A, Bellani G, et al. Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity. Crit Care Med 2008; 36: 2302-8
27. Sprong T, Peri G, Neeleman C, et al. Pentraxin 3 and C-reactive protein in severe meningococcal disease. Shock 2009; 31: 28-32
28. Mairuhu AT, Peri G, Setiati TE, et al. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. J Med Virol 2005; 76: 5
29. Roth E, Manhart N, Wessner B. Assessing antioxidative status in critically ill patients. Curr Opin Clin Nutr Metab Care 2004; 7: 161-8
30. Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG. Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 1991; 17: 40-4
31. Goodman AR, Levy DE, Reis LF, Vilcek J. Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages. J Leukoc Biol 2000; 67: 387-95
32. Sun Y, Oberley LW. Redox regulation of transcriptional activators. Free Rad Biol Med 1996; 21: 335-48
33. Paterson RL, Galley HF, Dhillon JK, Webster NR. Increased nuclear factor kappa B activation in critically ill patients who die. Crit Care Med 2000; 28: 1047-51
34. Böhrer H, Qiu F, Zimmermann T, et al. Role of NFkappaB in the mortality of sepsis. J Clin Invest 1997; 100: 972-85
35. Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor kB activation, interleukin-6, interleukin-8 and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2003; 31: 2574-8
36. MacDonald J, Galley HF, Webster NR. Oxidative stress and gene expression in sepsis. Br J Anaesth 2003; 90: 221-32
37. Ebadi M, Sharma SK, Wanpen S, Amornpan A. Coenzyme Q10 inhibits mitochondrial complex-1 down-regulation and nuclear factor-kappa B activation. J Cell Mol Med 2004; 8: 213-22
38. Bochkov VN, Leitinger N. Anti-inflammatory properties of lipid oxidation products. J Mol Med 2003; 81: 613-26
39. Uchida K. Lipid peroxidation and redox-sensitive signaling pathways. Curr Atheroscler Rep 2007; 9: 216-21
40. Yamasaki K, Kurimura M, Kasai T, Sagara M, Kodama T, Inoue K. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations. Clin Chem Lab Med 2009; 47: 471-7